C19orf53 is known to be associated with Leydig cell tumors which are a member of the sex cord-stromal tumor group of ovarian and testicular cancers and it has a potential role in hypercalcemia of malignancy [22]. This evidence concerns the gene C19orf53 and hypercalcemia disease.